Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease (vol 85, pg 1101, 2002)

被引:3
作者
Matsubara, E [1 ]
Bryant-Thomas, T
Pacheco, J
Henry, TL
Poeggeler, B
Herbert, D
Cruz-Sanchez, F
Chyan, YJ
Smith, MA
Perry, G
Chain, DG
Neria, E
Shoji, M
Abe, K
Leone, A
Grundke-Iqbal, I
Wilson, GL
Ghiso, J
Williams, C
Refolo, LM
Pappolla, MA
机构
[1] Okayama Univ, Grad Sch Med & Dent, Okayama 7008530, Japan
[2] Univ S Alabama, Mobile, AL 36688 USA
[3] Univ Int Catalunya, Inst Neurol & Gerontol Sci, Barcelona, Spain
[4] Case Western Reserve Univ, Cleveland, OH 44106 USA
[5] Oxonon, Emeryville, CA USA
[6] New York Inst Basic Res, New York, NY USA
[7] NYU, New York, NY USA
[8] Duke Univ, Durham, NC USA
[9] Inst Study Aging, New York, NY USA
[10] Mindset Biopharmaceut, Jerusalem, Israel
关键词
D O I
10.1046/j.1471-4159.2003.01997.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:1312 / 1312
页数:1
相关论文
共 1 条
[1]   Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease [J].
Matsubara, E ;
Bryant-Thomas, T ;
Quinto, JP ;
Henry, TL ;
Poeggeler, B ;
Herbert, D ;
Cruz-Sanchez, F ;
Chyan, YJ ;
Smith, MA ;
Perry, G ;
Shoji, M ;
Abe, K ;
Leone, A ;
Grundke-Ikbal, I ;
Wilson, GL ;
Ghiso, J ;
Williams, C ;
Refolo, LM ;
Pappolla, MA .
JOURNAL OF NEUROCHEMISTRY, 2003, 85 (05) :1101-1108